Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB
Oslo, 22 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals and pharmacies, has today amended its cash offer to acquire all shares in Sensidose AB (the "Offer") and at the same time agreed to purchase 6,837,016 shares in Sensidose AB representing 57.2% of the outstanding shares. The Sensidose shares are currently listed on Spotlight Stock Market in Sweden.Navamedic ASA ("Navamedic") has today amended its Offer to SEK 8.00 per share in Sensidose AB ("Sensidose") representing a total purchase price of approximately SEK 96 million